[Federal Register Volume 73, Number 164 (Friday, August 22, 2008)]
[Notices]
[Page 49688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-19442]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Advisory Neurological Disorders and Stroke Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council; Clinical Trials Subcommittee.
    Date: September 18, 2008.
    Closed: 8 a.m. to 9 a.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
    Open: 9 a.m. to 10 a.m.
    Agenda: To discuss clinical trials policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Deborah G Hirtz, MD, Acting Director, Clinical 
Trials Cluster, National Institute of Neurological, Disorders and 
Stroke, National Institute of Health, 6001 Executive Blvd., Suite 
2212, Bethesda, MD 20892, (301) 496-5821, <a href="/cdn-cgi/l/email-protection#92fafbe0e6e8d2fcfbfcf6e1bcfcfbfabcf5fde4"><span class="__cf_email__" data-cfemail="741c1d06000e341a1d1a10075a1a1d1c5a131b02">[email protected]</span></a>.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to NeurologicalDisorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: August 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-19442 Filed 8-21-08; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>